VP-315LTX-315BCCbasal cell carcinoma
…esting a reset of the immune switch toward anti-tumor immunity. VP-315 is a promising treatment for non-surgical first line BCC therap…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…esting a reset of the immune switch toward anti-tumor immunity. VP-315 is a promising treatment for non-surgical first line BCC therap…
…LPs have also shown remarkable clinical efficacy. For instance, LTX-315 (studied as VP-315 in basal cell carcinoma (BCC)) has recently …